Arvind Remedies announced its financial results for the first quarter ended June 30th 2014.The net sales for Q1FY14-15 increased by 40 per cent to Rs 258 crores as compared to Rs 184 crores of Q1FY13-14. EBIDTA for Q1FY14-15 registered a growth of 57 per cent to Rs 63 crores as compared to Rs 40 crores in Q1FY13-14. PAT for Q1FY14-15 grew by 53 per cent to Rs 26 crores as against Rs17 crores in Q1FY13-14.
Dr Arvind Shah, Managing Director and Chief Executive Officer, Arvind Remedies said, “The results are in line with our expectations. We continue to focus on the retail brand business and increase our presence in the domestic brand market.”
EP News Bureau- Mumbai
- Advertisement -
